Company Filing History:
1 out of 11 
1 out of 5,094 
Years Active: 2012
Title: Emmanuel Tetaud: Innovator in Mitochondrial Research
Introduction
Emmanuel Tetaud is a notable inventor based in Pessac, France. He has made significant contributions to the field of mitochondrial research, particularly in relation to NARP syndrome. His work focuses on the genetic mutations that affect ATP production, which is crucial for cellular energy.
Latest Patents
Emmanuel Tetaud holds a patent for "Modified yeast cells comprising at least one mutation of the tryptophan 136 (W), leucine 183 (L), or leucine 247 (L) codon of the mitochondrial ATP6 gene." This invention is particularly relevant for screening medicaments that target mitochondrial pathologies, including NARP syndrome. He has 1 patent to his name.
Career Highlights
Throughout his career, Tetaud has worked with prestigious institutions such as Université Victor Segalen—Bordeaux 2 and the Centre National de la Recherche Scientifique. His research has contributed to a deeper understanding of mitochondrial dysfunctions and their implications for human health.
Collaborations
Emmanuel Tetaud has collaborated with notable colleagues, including Jean-Paul Di Rago and Malgorzata Rak. Their combined expertise has furthered advancements in the field of mitochondrial research.
Conclusion
Emmanuel Tetaud's innovative work in mitochondrial research highlights the importance of genetic studies in understanding and treating complex diseases. His contributions continue to pave the way for future advancements in medical science.